Lilly Responsibilities Clause Samples

Lilly Responsibilities. Lilly will be responsible for all costs and expenses associated with the Lilly Research Activities.

Lilly Responsibilities. Prior to [**] in the People’s Republic of China, Lilly will be responsible for all Commercialization activities for the Products [**] except for the activities which ▇▇▇▇▇▇▇▇▇ shall be responsible for in the SOTC Areas as set forth in the 2018 Services and Demand Realization Agreement. Following [**] in the People’s Republic of China, Lilly will be responsible for all Commercialization activities for the Products in the Lilly Territory, and will be responsible for all Commercialization activities that do not constitute P&D Services for the Products in the Service Territory, except for the activities which ▇▇▇▇▇▇▇▇▇ shall be responsible for in the SOTC Areas as set forth in the 2018 Services and Demand Realization Agreement. [**] ▇▇▇▇▇▇▇▇▇ shall ensure its P&D Services are carried out in accordance with and in compliance with this Agreement and Regulatory Approvals and Applicable Laws. [**]

Lilly Responsibilities. Lilly will be responsible for all Commercialization activities for the Products [**] [**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.

Lilly Responsibilities. (a) Subject to Sections 4.1.2(a) and 5.6, after IND Filing Readiness, Lilly will be responsible for all further Development activities for the initial Licensed Product, including filing of the IND for such initial Licensed Product; and will also be responsible for all research and Development activities with respect to any second or subsequent Licensed Products (collectively, the “Lilly Research Activities”). For clarity, subject to Sections 4.1.2(a) and 5.6 and without limiting Sigilon’s supply-related obligations hereunder (including under Sections 7.5 and 7.6) and under any other written agreement between the Parties, Sigilon shall have no obligation to assist in the development of or fund any activities with respect to any Licensed Products other than as expressly provided under the Research Plan, unless mutually agreed by the Parties in writing. (b) Following Lilly’s approval of the IND Filing Package, Lilly agrees to use Commercially Reasonably Efforts to file within [***] months from such approval, in its own name, such IND Filing Package with the proper Regulatory Authority; provided, that, if at any time Lilly anticipates it will not file within such [***] month period, then Lilly will promptly notify Sigilon of such anticipated delay (and in any event, no later than [***] days following Lilly’s determination that new information unavailable at the time of such approval may cause such a delay) and the Parties will discuss the reasons for such delay, including any new information or factors that have arisen since Lilly’s approval of the IND Filing Package. Lilly shall provide or make available to Sigilon a copy of the IND Filing Package in the form submitted to such Regulatory Authority within [***] days following filing thereof. Lilly shall pay all filing fees associated with such filing.

Lilly Responsibilities. Subject to FACILITY’S compliance with its responsibilities, LILLY will pay FACILITY an upfront discount off floating NWP during the term of the ENROLLMENT based on the discount schedule set forth below and as set forth in full in MMCAP contract MMS24153. Loss of eligibility to receive upfront discount shall be the sole remedy available for the failure of FACILITY to provide Equal and Unrestricted Formulary Status as described in ENROLLMENT. In the case of disputed payments, LILLY shall pay the undisputed amount subject to the terms of the ENROLLMENT and shall endeavor to resolve the dispute promptly.

Lilly Responsibilities. (a) Subject to Sections 4.1.2 and 2.4, Lilly will be responsible for the Research activities assigned to it in the Research Plan and for all further Research and Development activities for the Products other than Aduro Research Activities (collectively, the “Lilly Research Activities”). For clarity, subject to Sections 4.1.2 and 2.4 and under any other written agreement between the Parties, Aduro shall have no obligation to assist in the Development of or fund any activities with respect to any Products other than as expressly provided under the Research Plan, unless mutually agreed by the Parties in writing. [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. (b) Lilly shall use Commercially Reasonable Efforts to perform the Lilly Research Activities during the Research Term as soon as practical (consistent with good scientific practice), and shall commit such resources (including employees, agents, consultants, facilities, equipment and materials) as are reasonably necessary to comply with such diligence obligation. (c) Lilly shall be solely responsible for the safety and health of its employees, consultants and visitors, and for compliance with all Applicable Laws related to health, safety and the environment, including providing its employees, consultants and visitors with all required information and training concerning any potential hazards involved in performing such activities and any precautionary measures to protect its employees from any such hazards.

Lilly Responsibilities. Lilly will be resnonsible for all Commercialization activities [**]

Lilly Responsibilities. Lilly will be responsible for the following:

Lilly Responsibilities